Introduction to 2016 Wmif Disruptive Dozen 6
Exploring 2016 Wmif Disruptive Dozen 6 reveals several interesting facts. The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
2016 Wmif Disruptive Dozen 6 Comprehensive Overview
Machine Learning and Computational Biology to Transform Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH ... Epigenetics and Cancer Treatment Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. CRISPR: Genome Editing and Cancer Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
Immune Modulators (Checkpoint Inhibitors) and Vaccines Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical ...
Summary & Highlights for 2016 Wmif Disruptive Dozen 6
- 6
- Cellular Immunotherapy Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter D.
- Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ...
- Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease ...
- Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of Surgery, Harvard Medical School ...
Stay tuned for more updates related to 2016 Wmif Disruptive Dozen 6.
